The Sites of Degradation of Rat High-density-lipoprotein Apolipoprotein E Specifically Labelled with O-(4-diazo-3-[125I]iodobenzoyl)sucrose
Overview
Authors
Affiliations
O-(4-Diazo-3-[125I]iodobenzoyl)sucrose ([125I]DIBS), a novel labelling compound specifically designed to study the catabolic sites of serum proteins [De Jong, Bouma, & Gruber (1981) Biochem. J. 198, 45-51], was applied to study the tissue sites of degradation of serum lipoproteins. [125I]DIBS-labelled apolipoproteins (apo) E and A-I, added in tracer amounts to rat serum, associate with high-density lipoproteins (HDL) just like conventionally iodinated apo E and A-I. No difference is observed between the serum decays of chromatographically isolated [125I]DIBS-labelled and conventionally iodinated HDL labelled specifically in either apo E or apo A-I. When these specifically labelled HDLs are injected into fasted rats, a substantial [125I]DIBS-dependent 125I accumulation occurs in the kidneys and in the liver. No [125I]DIBS-dependent accumulation is observed in the kidneys after injection of labelled asialofetuin or human low-density lipoprotein. It is concluded that the kidneys and the liver are important sites of catabolism of rat HDL apo E and A-I.
Renal apolipoproteins in nephrotic rats.
van Goor H, van der Horst M, Atmosoerodjo J, Joles J, van Tol A, Grond J Am J Pathol. 1993; 142(6):1804-12.
PMID: 8506949 PMC: 1886974.
Metabolic fate of sphingomyelin of high-density lipoprotein in rat plasma.
Bentejac M, Bugaut M, Delachambre M, LECERF J Lipids. 1990; 25(10):653-60.
PMID: 2079870 DOI: 10.1007/BF02536017.